GRANULAR PRODUCT BASED ON ARGININE

Abstract

A granular product based on arginine or the derivatives thereof, comprises an internal core in which there is substantially concentrated the arginine and a coating for covering and protecting the internal core, wherein the coating is formed by a lipidic matrix comprising a fraction by weight equal to or greater than 60% of glycerides of saturated fatty acids C16 and C18 and a fraction by weight of a mineral salt of alginate between 0.5% and 3%.

Claims

1. A granular product based on arginine or the derivatives thereof, comprising an internal core in which there is substantially concentrated the arginine or the derivatives thereof and a coating for covering and protecting the internal core, wherein the coating is formed by a lipidic matrix comprising a fraction by weight equal to or greater than 60% of glycerides of saturated fatty acids C16 and C18 and a fraction by weight of a mineral salt of alginate comprised between 0.5% and 3%.

2. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight greater than 70% of glycerides of saturated fatty acids C16 and C18.

3. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight of fatty acid C18 equal to or greater than 80% with respect to the total of the fatty acids contained in the lipidic matrix.

4. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight of calcium stearate comprised between 1% and 10%.

5. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight of calcium hydroxide comprised between 1% and 5%.

6. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight of a monosaccharide or a disaccharide comprised between 1% and 10%.

7. The granular product according to claim 6, wherein the monosaccharide or disaccharide is trehalose.

8. The granular product according to claim 1, wherein the lipidic matrix comprises a fraction by weight of propylene glycol distearate comprised between 0.1% and 5%.

9. The granular product according to claim 1, wherein the glycerides are in the form of triglycerides, with a free acidity less than 2%.

10. Use of the granular product based on arginine or the derivatives thereof according to claim 1 as a food product which is intended for human consumption.

Description

EXAMPLE

[0068] In a liner type mixer, heated to the temperature of 70° C.-75° C., there are successively introduced: [0069] 393 g of hydrogenated soybean oil, [0070] 15 g of propylene glycol distearate, [0071] 500 g of powdered L-arginine, [0072] 30 g of calcium stearate, [0073] 30 g of trehalose, [0074] 20 g of calcium hydroxide, [0075] 10 g of sodium alginate, [0076] 2 g of flavourings and sweeteners.

[0077] The hydrogenated soybean oil used is formed by glycerides of fatty acids present at the percentages below: [0078] C12: 0-0.5%, [0079] C14: 0-1%, [0080] C16: 9-16%, [0081] C18: 79-90%.

[0082] The admixture is maintained under agitation for approximately 10 minutes in order to obtain a homogeneous suspension which is then supplied to a cool chamber which is maintained at a temperature of approximately −10° C. In the cool chamber the admixture has been sprayed using a nozzle which is suitable for the desired grain size so as to obtain granules with an internal core which is based on arginine and which is coated with a lipidic matrix.

[0083] The granular product which is removed from the cool chamber is finally subjected to sieving in order to suitably delimit the dimensions of the finished product.